Arrowstreet Capital, Limited Partnership Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Arrowstreet Capital, Limited Partnership

  • $114 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $2.08 Million - $3.65 Million
24,993 Added 1100.53%
27,264 $3.97 Million
Q1 2022

May 13, 2022
BUY
$110.08 - $142.92 $249,991 - $324,571
2,271 New
2,271 $269,000
Q1 2021

May 14, 2021
SELL
$64.07 - $91.75 $694,454 - $994,478
-10,839 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$65.07 - $98.24 $705,293 - $1.06 Million
10,839 New
10,839 $929,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email